00:00
05:40
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews impressive results from the GALAXY-1 trial of the heat shock protein inhibitor ganetespib combined with combined with second line docetaxel in advanced lung adenocarcinoma.
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews impressive results from the GALAXY-1 trial of the heat shock protein inhibitor ganetespib combined with combined with second line docetaxel in advanced lung adenocarcinoma. read more read less

10 years ago #asco, #cancer, #cancergrace, #david, #dr, #edward, #geffen, #grace, #gracecast, #heat, #highlights, #hsp90, #inhibitor, #lung, #medicine, #of, #protein, #school, #shock, #ucla